We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Sildenafil: from angina to erectile dysfunction to pulmonary hypertension and beyond.
- Authors
Ghofrani, Hossein A; Osterloh, Ian H; Grimminger, Friedrich
- Abstract
In less than 20 years, the first selective type 5 phosphodiesterase inhibitor, sildenafil, has evolved from a potential anti-angina drug to an on-demand oral treatment for erectile dysfunction (Viagra), and more recently to a new orally active treatment for pulmonary hypertension (Revatio). Here we describe the key milestones in the development of sildenafil for these diverse medical conditions, discuss the advances in science and clinical medicine that have accompanied this journey and consider possible future indications for this versatile drug.
- Publication
Nature reviews. Drug discovery, 2006, Vol 5, Issue 8, p689
- ISSN
1474-1776
- Publication type
Journal Article
- DOI
10.1038/nrd2030